Tue.Jun 10, 2025

article thumbnail

Opinion: We have ‘post-vaccination syndrome.’ We are tired of being used to score anti-vax points

STAT

We recently went viral. Well, not exactly us — but people like us. We are participants in the Yale LISTEN Study , a patient-centered study to better understand long Covid and the adverse effects some patients have experienced post Covid-vaccination. We are members of the post-vaccination cohort, a group that includes more than 250 patients.

Vaccines 361
article thumbnail

Takeda presents positive results from trial of chronic kidney disease treatment

Pharmafile

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab. The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafi

116
116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: STAT+: HBCUs can help create a 21st-century bioeconomy and the talent pipeline it requires

STAT

Biotechnology has become a pillar of national resilience. Once considered niche, fields like synthetic biology, pathogen genomics, computational biology, and environmental microbiology now sit at the heart of U.S. biosecurity strategy, economic competitiveness, and geopolitical influence. Yet the nation’s training infrastructure remains dangerously underdeveloped.

216
216
article thumbnail

The former Wall Street analyst shaping Novartis’ big-picture strategy

PharmaVoice

Ronny Gal, chief strategy and growth officer at Novartis, is guiding the company into a new era shaped by science-minded M&A and a slimmed-down pivot.

130
130
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Sarah Huckabee Sanders: Republicans Can Lead on This Health Care Issue

NY Times

Pharmacy benefit managers have used anti-competitive practices to dominate the prescription drug market.

96

More Trending

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

Beyfortus now has a direct rival after FDA OK for Enflonsia

pharmaphorum

MSD could soon enter the US market for drugs used to protect infants from RSV infections, setting up a rivalry with AstraZeneca/Sanofi's Beyfortus

100
100
article thumbnail

Tagomics secures £860k grant for colorectal cancer test

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Tagomics secures £860k grant for colorectal cancer test by John Pinching | 10th Jun 2025 | News Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k in funding from Innovate UK’s Biomedical Catalyst programme to develop a novel diagnostic test for colorectal cance

93
article thumbnail

How to check if a drug is patented?

Drug Patent Watch

The Secret to Unlocking Affordable Medication: A Simple 3-Step Guide to Checking if Your Prescription is Tied Up in Patent Red Tape As the cost of prescription medication continues to skyrocket, it's more crucial than ever to understand the complex world of pharmaceutical patents. But do you know if the medication you're taking is protected by a patent?

73
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vaccine makers face fresh uncertainty after firing of CDC panel

BioPharma Dive

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.

Vaccines 110
article thumbnail

Lubrizol announces an important milestone for its novelpatented excipient, Apisolex™ polymer

Pharmafile

June 10, 2025 – Lubrizol announces that an Apisolex™ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-basedpolymer that enhances the solubility of BCS Class II and IV active pharmaceuticalingredients (API). Apisolex polymer excipient is manufactured following GoodManufacturing Practices (GMP) guidelines and […] The post Lubrizol announces an important milestone for its novelpatent

64
article thumbnail

RPS to continue providing pharmacist trainee tool

The Pharmacist

Pharmacist trainees can continue to access the e-Portfolio for foundation-year as the Royal Pharmaceutical Society (RPS) has been awarded a contract extension. The RPS will deliver the NHS England Foundation Trainee Pharmacist Programme e-Portfolio for another year after NHS England extended the contract, which began in 2021. Powered by Axia Digital, the tool provides support […] The post RPS to continue providing pharmacist trainee tool appeared first on The Pharmacist.

59
article thumbnail

MSD moves ahead in race to bring oral PCSK9 drug to market

pharmaphorum

Armed with positive results in two phase 3 trials, MSD is poised to be the first to file for approval of an oral PCSK9 drug to lower cholesterol

59
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

PharmaTech

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic treatment.

59
article thumbnail

Transforming drug development with statistical methodologies

pharmaphorum

Discover how statistical methodologies are transforming drug development by leveraging real-world evidence (RWE) to improve decision-making and outcomes. Explore the impact and benefits of utilising RWE in pharmaceutical research.

article thumbnail

Bridging Access Gaps

Pharmaceutical Commerce

In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and digital solutions can be deployed effectively to close the gap in areas identified as pharmacy deserts.

52
article thumbnail

Fermenting legume pulses boosts their antidiabetic, antioxidant properties

World Pharma News

Food scientists at the University of Illinois Urbana-Champaign identified the optimal fermentation conditions for pulses - the dried edible seeds of legumes - that increased their antioxidant and antidiabetic properties and their soluble protein content. Using the bacteria Lactiplantibacillus plantarum 299v as the microorganism, the team fermented pulses obtained from varying concentrations of black bean, black-eyed pea, green split pea, red lentil and pinto bean flours.

70
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Investment in NHS app will reduce the need for 50 million letters says DHSC

The Pharmacist

More patients will receive appointment reminders, screening invitations and test results directly to their smartphones within the next three years, the Department of Health and Social Care (DHSC) says. More than £50m is to be invested in the NHS app to increase the number of messages it sends this year by 70 million from the […] The post Investment in NHS app will reduce the need for 50 million letters says DHSC appeared first on The Pharmacist.

59
article thumbnail

The 340B Contract Pharmacy Market in 2025: Big Chains and PBMs Tighten Their Grip

Drug Channels

The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). Drug Channels Institute’s latest exclusive analysis of the 2025 market reveals a highly concentrated market structure increasingly dominated by a handful of major players: About 32,000 pharmacy locations—nearly 60% of the entire U.S. pharmacy industry—function as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

article thumbnail

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Parexel completes CRO registration with CDSCO under new G.S.R 581(E) regulation

Express Pharma

Parexel, a global clinical research organisation (CRO) offering Phase I to IV clinical development services, has announced the successful completion of its registration with the Central Drugs Standard Control Organisation (CDSCO). This move is in compliance with the Government of India’s G.S.R 581(E) regulation, which mandates CROs operating in India to register with CDSCO.

66
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

CMS Patient Engagement Roundtable: Medicare Drug Pricing

Putting Patients First Blog

CMS Patient Engagement Roundtable: Medicare Drug Pricing Event Time: 2:00 - 4:30 p.m. ET Event Location: Private (Invitation Only) The National Health Council (NHC) is pleased to host a roundtable discussion with the Centers for Medicare & Medicaid Services (CMS) on Monday, June 30 , from 2:00 to 4:30 p.m. ET. This session continues the ongoing dialogue between CMS and the patient community, focusing on the implementation of the Medicare Drug Price Negotiation Program.

article thumbnail

EC approves Alnylam’s vutrisiran for ATTR-CM treatment

Pharmaceutical Technology

The EC has approved Alnylam Pharmaceuticals' Amvuttra (vutrisiran) to treat wild-type or hereditary ATTR-CM in adults.

52
article thumbnail

Neowise and BeOne Medicines sign agreement for cell therapy development

Pharmaceutical Business Review

Under the agreement, Neowise will be eligible for an upfront payment and will also receive future milestone payments. These payments are contingent upon reaching specific development, regulatory, and commercial milestones. Additionally, Neowise will earn royalties from the commercialisation of the cell therapy products developed by BeOne. The financial details of the agreement have not been disclosed.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ANGLE’s Parsortix system used in new cancer biology research

Pharmafile

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in studies exploring cancer biology and therapeutic targets. The research, led by academic groups in Germany, Ireland and the US, supports the system’s growing role in advancing oncology R&D. In one study, published in Journal of […] The post ANGLE’s Parsortix system used in new cancer biology research appeared first on Pharmafile.

59
article thumbnail

The Connection Between Virtual Care and Language Barriers

Pharmaceutical Commerce

A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care option, while exploring equity and accessibility gaps when it comes to telehealth.

52
article thumbnail

Dismay as RFK Jr ousts CDC vaccine advisors

pharmaphorum

RFK Jr has removed all 17 members of the CDC's vaccine advisory committee in a move that some fear could lead to restrictions on immunisation access